Welcome
Support Centre
22 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Improving maternal and newborn health in rural areas of Jharkhand and Orissa through the empowerment of tribal communities
ISRCTN ISRCTN21817853
DOI 10.1186/ISRCTN21817853
ClinicalTrials.gov identifier
EudraCT number
Public title Improving maternal and newborn health in rural areas of Jharkhand and Orissa through the empowerment of tribal communities
Scientific title
Acronym N/A
Serial number at source 03PC03
Study hypothesis Will a community mobilisation intervention improve maternal and neonatal home care, service uptake, morbidity and mortality and maternal depression in tribal communities in Jharkhand and Orissa, India?
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from an Independant Ethics Committee (chaired by Dr A.K. Debdas), 14/06/2005.
Study design Cluster randomised controlled trial
Countries of recruitment India
Disease/condition/study domain Maternal and child health
Participants - inclusion criteria Women (no defined age range) who reside in 36 predominantly tribal communities during the study period
Participants - exclusion criteria Women who decline to be interviewed or reside outside the study area
Anticipated start date 01/08/2005
Anticipated end date 01/02/2008
Status of trial Completed
Patient information material
Target number of participants 9000
Interventions In each intervention cluster a facilitator will convene community groups to explore maternal and neonatal health issues. Groups will meet once or twice monthly and move through action research cycles. The programme inputs can be itemised as:
1. Recruitment, training, supervisions and remuneration of facilitators. The role of the facilitator is to activate and strengthen groups, support them in identifying problems, help to plan possible solutions and support the implementation and monitoring of solution strategies in the community. Although she requires a grasp of health issues and some knowledge of potential interventions, she needs to be a facilitator rather than a teacher. As such, she may act as a broker of information and communication but her prime importance is as a catalyst for community mobilisation
2. Development of tools for conducting group meetings, process evaluation and documentation
3. Recruitment, training, supervision and remuneration of a supervisory cadre to support the community-based facilitators

There is no follow-up period after the intervention ends. The intervention is a community mobilisation intervention, which only occurs in the intervention clusters. All clusters, control and intervention, receive health system strengthening activities.
Primary outcome measure(s) Neonatal and maternal mortality rates, measured prospectively from 01/08/2005 until the end of the trial (likely to be February 2008).
Secondary outcome measure(s) 1. Maternal and neonatal home care practices
2. Utilisation of antenatal, delivery and postnatal services
3. Maternal depression

All outcomes measured prospectively from 1st August 2005 until the end of the trial (likely to be February 2008).
Sources of funding 1. The Health Foundation (UK) (ref: 1748/3001)
2. The Department For International Development (DFID) (UK) (ref: HPD KP 14)
Trial website
Publications 2010 results in: http://www.ncbi.nlm.nih.gov/pubmed/20207411
Contact name Dr  Sarah  Barnett
  Address 30 Guilford Street
  City/town London
  Zip/Postcode WC1N 1EH
  Country United Kingdom
Sponsor The Institute of Child Health (UK)
  Address University College London (UCL)
30 Guilford Street
  City/town London
  Zip/Postcode WC1N 1EH
  Country United Kingdom
  Sponsor website: http://www.ich.ucl.ac.uk
Date applied 19/11/2007
Last edited 10/10/2014
Date ISRCTN assigned 05/12/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.